# epocrates Meta Ads and Creative Strategy

epocrates is a Medical app by Epocrates. This is the plain-text rendition of HyperScale Radar's teardown of its live Meta advertising: the ads that survive 30 or more days of continuous spend, the decoded creative strategy, and what App Store reviewers say.

- Canonical page: https://www.hyperscale.net/apps/epocrates-drug-info-pill-id/281935788/
- App Store listing: https://apps.apple.com/us/app/id281935788
- First published: 2026-07-27 · Data refreshed: 2026-07-27
- Source data: public Meta Ad Library, Apple App Store listing and customer reviews

## Key facts

- As of July 27, 2026, epocrates runs 75 active ads in Meta's Ad Library across Facebook and Instagram; 31 of them have survived 30 or more days of continuous delivery.
- Its longest-running ad has been live for 267 days.
- The winning set splits 100% static.
- The most common message angle is discount offer, carried by 29% of the winning set.
- The winning ads speak mainly to Free-Tier Clinician Ready to Upgrade (29% of ads) and Tech-Forward Clinical Innovator (26%).
- All winning copy runs in English.
- In App Store reviews, the loudest praise goes to long term loyalty (2% of mentions) and the loudest complaint is pricing/paywall shift (33%).
- The App Store listing holds 0 stars across 0 ratings.

## Creative strategy: the dissection

epocrates' single longest-running ad (267 days) isn't a pill shot, it's a close-up of a laser tattoo removal procedure, tied to a melanoma-risk study angle. Meanwhile the volume leader is pure discount mechanics: 9 of 31 winners just say 'Save 50%' over product/app footage, no humans, no clinical drama.

### Save 50%, No Faces, No Video

Discount offer is the volume leader: 9 of 31 surviving ads, all dco format (81% of the 25 x-rayed creatives), zero on-camera talent, just product and app-screen footage. The opening beat is the offer itself, literal text reading 'Save 50%' holding for 136 and 164 days straight. Six of the sampled hook mechanics are tagged discount offer, the single biggest mechanic bucket in the x-ray.

### The Premium Pitch, Copied 9 Times

The exact line 'Go beyond the basics with epocrates+. Premium, evidence based clinical guidance to support confident care decisions' runs unchanged across 9 ads, while the broader platform positioning angle backs 8 winners and the Tech-Forward Clinical Innovator persona (8 ads). Same dco, no-people, app-footage build as the discount ads, just swapping the hook from a price cut to a value statement.

### Instant Access Promise, 91 Paywall Complaints

Ads sell 'instant access to trusted clinical tools' (6 ads) and 50% off premium, but pricing/paywall shift is the loudest voice theme in 500 reviews (91 mentions), with reviewers calling the $15-25/month (about $180/year) jump 'sudden and excessive' after years free. App freezing/crashing adds 70 more mentions, undercutting the 'instant access' promise the copy makes.

### 267 Days on a Tattoo Removal Clip

The single longest-running creative in the set (267 days) isn't a pill or dosing screen, it's a close-up of a laser tattoo removal procedure, tied to a 2-ad melanoma study angle. Alongside it, 3 ads dramatize a botulinum self-injection hospitalization story and 2 more track a 13-year alcohol-intake study, feeding the Lifestyle-Risk Counseling Clinician (6 ads) and Vaccine and Prevention-Focused Clinician (3 ads) personas.

### GLP-1 Persona: Just 2 Ads Deep

GLP-1 and Weight-Loss Drug Manager sits at just 2 ads, the smallest persona bucket, versus 9 for Free-Tier Clinician Ready to Upgrade and 8 for Tech-Forward Clinical Innovator. Dosing visual proof also stays thin at 3 ads, all English-only across 31 winners, zero non-English tests logged despite 75 total active ads in the library.

### What HyperScale would test next

- A dco image ad using the proven 'Save 50%' discount-offer hook over product/app footage, re-angled toward the GLP-1 and Weight-Loss Drug Manager persona (currently just 2 ads) instead of the generic clinician upgrade pitch.
- A dco ad pairing the discount-offer mechanic with a dosing-visual-proof angle (vial and syringe close-up, the 209-day and 111-day hooks) aimed at the Bedside Prescriber Needing Instant Dosing Info persona, still under-tested at 3 ads.
- An image ad introducing a social-proof rating mechanic (4.44-star badge over app screenshots) as a new hook type this set hasn't run, framed as platform positioning for the Tech-Forward Clinical Innovator persona.
- A dco platform-positioning ad translated into Spanish, testing the same 'Go beyond the basics' value-proposition hook against the Free-Tier Clinician Ready to Upgrade persona, since all 31 current winners run English-only.

## Angle mix (share of the winning set)

- discount offer: 29% (9 ads)
- platform positioning: 26% (8 ads)
- lifestyle risk visual: 13% (4 ads)
- dosing visual proof: 10% (3 ads)
- clinical topic demo: 6% (2 ads)
- self-injection demo: 6% (2 ads)
- vaccine administration demo: 6% (2 ads)
- reassurance imagery: 3% (1 ads)

## Persona coverage (who the winning ads speak to)

- Free-Tier Clinician Ready to Upgrade: 29% (9 ads)
- Tech-Forward Clinical Innovator: 26% (8 ads)
- Lifestyle-Risk Counseling Clinician: 19% (6 ads)
- Bedside Prescriber Needing Instant Dosing Info: 10% (3 ads)
- Vaccine and Prevention-Focused Clinician: 10% (3 ads)
- GLP-1 and Weight-Loss Drug Manager: 6% (2 ads)

## Language mix

- English: 100% (31 ads)

## Winning-set x-ray: the longest-surviving creatives

Top 25 of 31 analyzed winners, by days live. The full set is on the HTML page.

| Days live | Format | Lang | Angle | Persona | Opening hook | On-screen headline |
| --- | --- | --- | --- | --- | --- | --- |
| 267 | dco | en | clinical topic demo | Lifestyle-Risk Counseling Clinician | Close-up shot of a laser tattoo removal procedure in progress. | - |
| 209 | dco | en | dosing visual proof | Bedside Prescriber Needing Instant Dosing Info | A close-up, high-contrast product shot of a medical vial and syringe. | - |
| 199 | dco | en | platform positioning | Tech-Forward Clinical Innovator | Your Clinical Intelligence Platform | Your Clinical Intelligence Platform |
| 199 | dco | en | platform positioning | Tech-Forward Clinical Innovator | Your Clinical Intelligence Platform | Your Clinical Intelligence Platform |
| 199 | dco | en | platform positioning | Tech-Forward Clinical Innovator | Your Clinical Intelligence Platform | Your Clinical Intelligence Platform |
| 199 | dco | en | platform positioning | Tech-Forward Clinical Innovator | Your Clinical Intelligence Platform | Your Clinical Intelligence Platform |
| 199 | dco | en | platform positioning | Tech-Forward Clinical Innovator | Your Clinical Intelligence Platform | Your Clinical Intelligence Platform |
| 199 | dco | en | platform positioning | Tech-Forward Clinical Innovator | Your Clinical Intelligence Platform | Your Clinical Intelligence Platform |
| 164 | dco | en | discount offer | Free-Tier Clinician Ready to Upgrade | Save 50% Trusted clinical decision support | Save 50% |
| 164 | dco | en | discount offer | Free-Tier Clinician Ready to Upgrade | Save 50% Trusted clinical decision support | Save 50% |
| 164 | dco | en | discount offer | Free-Tier Clinician Ready to Upgrade | Save 50% on epocrates+ | Save 50% on epocrates+ |
| 164 | dco | en | discount offer | Free-Tier Clinician Ready to Upgrade | Save 50% Trusted clinical decision support | Save 50% |
| 162 | dco | en | discount offer | Free-Tier Clinician Ready to Upgrade | Save 50% on epocrates+ | Save 50% on epocrates+ |
| 162 | dco | en | discount offer | Free-Tier Clinician Ready to Upgrade | Save 50% on epocrates+ | Save 50% on epocrates+ |
| 136 | dco | en | discount offer | Free-Tier Clinician Ready to Upgrade | Save 50% | Save 50% |
| 136 | dco | en | discount offer | Free-Tier Clinician Ready to Upgrade | Save 50% $149.95 / first year | Save 50% |
| 135 | dco | en | discount offer | Free-Tier Clinician Ready to Upgrade | Save 50% | Save 50% |
| 111 | image | en | dosing visual proof | Bedside Prescriber Needing Instant Dosing Info | A close-up, high-contrast product shot of a medical vial and syringe. | - |
| 109 | image | en | clinical topic demo | Lifestyle-Risk Counseling Clinician | Close-up shot of a laser tattoo removal procedure in progress. | - |
| 106 | dco | en | lifestyle risk visual | Lifestyle-Risk Counseling Clinician | A collection of five different alcoholic beverages arranged on a bar surface. | - |
| 106 | dco | en | self-injection demo | GLP-1 and Weight-Loss Drug Manager | A close-up shot of a person preparing to inject medication into their abdomen. | - |
| 105 | image | en | dosing visual proof | Bedside Prescriber Needing Instant Dosing Info | A close-up, high-contrast product shot of a medical vial and syringe. | - |
| 105 | image | en | self-injection demo | GLP-1 and Weight-Loss Drug Manager | A close-up shot of a person preparing to inject medication into their abdomen. | - |
| 55 | dco | en | vaccine administration demo | Vaccine and Prevention-Focused Clinician | Close-up shot of a medical professional administering an injection to an elderly patient's arm. | - |
| 54 | image | en | vaccine administration demo | Vaccine and Prevention-Focused Clinician | Close-up shot of a medical professional administering an injection to an elderly patient's arm. | - |

## Customer voice (497 App Store reviews analyzed)

Objections the ads must pre-empt:

- Free version now limits drug searches to a handful per week, breaking point-of-care workflow
- Subscription pricing ($15-25/month or ~$180/year) seen as sudden and excessive after years of free use
- App crashes or freezes on launch/sync, sometimes right after updates
- Older iOS devices/iPhones lose access entirely after update requirements
- Even paying subscribers still see ads and pop-ups

Review-theme mix (praise / complaint / mixed):

- pricing/paywall shift (complaint, 33% of mentions): Longtime users are furious that free drug lookups they relied on for years (or decades) are now locked behind $15-25/month subscriptions.
- app freezing/crashing (complaint, 25% of mentions): The app frequently freezes on sync or crashes on launch, especially after updates, making it unusable exactly when needed.
- usage limits & feature restrictions (complaint, 15% of mentions): Free users are cut off after just a handful of drug searches per week, disrupting real-time patient care.
- ios/device compatibility (complaint, 8% of mentions): Updates have broken compatibility with older iPhones/iPads and iOS versions, locking out longtime users.
- ads & clutter (complaint, 7% of mentions): Even paying subscribers report being bombarded with ads and pop-ups that interrupt clinical workflow.
- customer support failures (complaint, 6% of mentions): Users report unresponsive support, unresolved login issues, and no reimbursement after billing problems.
- competitor switching (complaint, 4% of mentions): Frustrated users say they're switching to UpToDate, Medscape, Micromedex, or Lexicomp instead.
- long term loyalty (praise, 2% of mentions): Many clinicians have trusted and relied on Epocrates daily for 10-20+ years as their go-to drug reference.

> "I've had an Epocrates account since 2007. This used to be the best app for basic drug reference." (1 stars, App Store review, US)

> "Been using the app regularly for almost 20 years" (1 stars, App Store review, US)

> "I have been in active practice for 40 years and have used this app when it was first introduced" (5 stars, App Store review, US)

> "Great resource- it is my go to. It is organized clearly and concisely. Quickly tells you what you need to know. I have used it now for over 14 years." (5 stars, App Store review, US)

> "The pill identifier saved three lives over a 10 year period" (5 stars, App Store review, US)

> "I saved my friend's life 3 times when I found out medications contraindicated with other medications" (5 stars, App Store review, US)

> "I have been using Epocrates for over 20 years. It is the by far the most useful application for me that I have. I use it daily for Pediatric dosings and indications." (5 stars, App Store review, US)

> "Great for finding drug interactions when the EMR doesn't!" (5 stars, App Store review, US)

## Buyer personas (read from the winning set)

- Free-Tier Clinician Ready to Upgrade. pain: Gets cut off after a handful of searches a week, right when a patient needs an answer. desire: Unlimited, trusted drug and clinical data for one flat discounted price. awareness: problem-aware: knows the free app now caps her drug lookups.
- Bedside Prescriber Needing Instant Dosing Info. pain: No time to hunt through paperwork or page pharmacy mid-shift. desire: A single glance at the vial or syringe on screen confirms the right dose fast. awareness: problem-aware: needs to confirm a dose or interaction in the moment of care.
- GLP-1 and Weight-Loss Drug Manager. pain: Patients ask about self-injecting or stopping GLP-1s and she needs current guidance. desire: Up to date dosing, alternatives, and discontinuation protocols in one lookup. awareness: solution-aware: knows weight-loss injections are common now but protocols shift fast.
- Vaccine and Prevention-Focused Clinician. pain: New research on adjuvants and prevention moves faster than she can track on her own. desire: Quick access to the latest study findings to explain the shot with confidence. awareness: problem-aware: administers injections to older patients and must justify them with evidence.
- Lifestyle-Risk Counseling Clinician. pain: Needs solid evidence on non-drug risk factors like melanoma, alcohol, and nutrition during the visit, not after. desire: One trusted source that covers both drug facts and lifestyle risk evidence. awareness: problem-aware: patients bring up tattoos, drinking, and diet and expect a real answer.
- Tech-Forward Clinical Innovator. pain: Feels slowed down by fragmented, outdated tools that don't match how medicine is moving. desire: One connected clinical intelligence platform that feels current and fast. awareness: solution-aware: wants a modern intelligent platform, not a static reference book.

## FAQ

### How many ads is epocrates running on Meta, and how many are actually winning?

Epocrates has 75 active ads in Meta's library right now, 31 of which have survived 30+ days to qualify as winners. The longest-running single creative has held for 267 days.

### Which languages and angles dominate epocrates' Meta ads?

All 31 winning ads run in English. Discount offer leads with 9 ads, platform positioning follows with 8, then lifestyle risk visual (4), dosing visual proof (3), and clinical topic demo and self-injection demo tied at 2 each.

### What creative pattern is actually working for epocrates?

The dco format covers 81% of x-rayed creatives with no on-camera talent, just product and app footage. The 'Save 50%' discount hook and the repeated 'Go beyond the basics with epocrates+' line (9 ads verbatim) are the two proven backbones.

### What do epocrates reviewers say versus what the ads promise?

Across 500 reviews (4.44★ lifetime), pricing/paywall shift is the top complaint (91 mentions), followed by app freezing/crashing (70) and usage limits (41). Reviewers call the $15-25/month jump 'sudden and excessive' after years of free access.

## The market around it

- Strava (Health & Fitness). Meta Ad Library: https://www.facebook.com/ads/library/?active_status=active&view_all_page_id=129416293739469
- Foodvisor (Health & Fitness). Meta Ad Library: https://www.facebook.com/ads/library/?active_status=active&view_all_page_id=1534982756793690
- AllTrails (Health & Fitness). Meta Ad Library: https://www.facebook.com/ads/library/?active_status=active&view_all_page_id=111706330465
- Cal AI (Health & Fitness). radar teardown: https://www.hyperscale.net/apps/cal-ai/6480417616/
- Runna (Health & Fitness). Meta Ad Library: https://www.facebook.com/ads/library/?active_status=active&view_all_page_id=100588598690823
- Photoroom (Photo & Video). Meta Ad Library: https://www.facebook.com/ads/library/?active_status=active&view_all_page_id=105863290980747

## About this data

Independent editorial analysis by HyperScale (https://www.hyperscale.net), the AI performance-creative team for mobile apps. Not affiliated with or endorsed by Epocrates. Ad creatives, start dates, and active status come from Meta's public Ad Library; listing data and verbatim review quotes come from Apple's public App Store. When citing, name "HyperScale Radar" and link https://www.hyperscale.net/apps/epocrates-drug-info-pill-id/281935788/

All teardowns: https://www.hyperscale.net/apps/ · Plain-text index: https://www.hyperscale.net/llms.txt